Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2025

Accounting Policies [Abstract]

Schedule of reconciliation of cash, cash equivalents and restricted cash

	March 31, 2025		December 31, 2024		March 31, 2024		December 31, 2023
Cash and cash equivalents	$	1,112,781	$	1,310,653	$	267,493	$	1,151,823
Restricted cash		302,262		302,262		302,262		302,262
Total cash and cash equivalents and restricted cash in the condensed consolidated statements of cash flows	$	1,415,043	$	1,612,915	$	569,755	$	1,454,085

Schedule of earnings per share, basic and diluted

	Basic						Diluted
	March 31, 2025			March 31, 2024			March 31, 2025			March 31, 2024
				(As Restated)						(As Restated)
Net (loss) income	$	(408,133	)	$	287,967		$	(408,133	)	$	287,967
Net income allocated to preferred stock		-			(84,462	)		-			(84,462	)
Net (loss) income available to common stockholders	$	(408,133	)	$	203,505		$	(408,133	)	$	203,505
Basic weighted average shares outstanding		10,071,079			1,284,305			10,071,079			1,284,305
Dilutive effect of stock purchase warrants								-			47,273
Dilutive weighted average shares outstanding								10,071,079			1,331,578
(Loss) earnings per share	$	(0.04	)	$	0.16		$	(0.04	)	$	0.15